IGFBP2 and type 2 diabetes mellitus: IGFBP2, has been extensively studied for its antidiabetic effects and as a potential T2D biomarker (17) and demonstrates a strong association with risk of T2D (70), although its causal relationship remains uncertain (17, 71).